Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sensus Healthcare (SRTS) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Sensus Healthcare (SRTS) over the last 10 years, with Q3 2025 value amounting to 37.32%.

  • Sensus Healthcare's EBITDA Margin fell 542300.0% to 37.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.25%, marking a year-over-year decrease of 441600.0%. This contributed to the annual value of 19.35% for FY2024, which is 209200.0% up from last year.
  • Per Sensus Healthcare's latest filing, its EBITDA Margin stood at 37.32% for Q3 2025, which was down 542300.0% from 26.56% recorded in Q2 2025.
  • Sensus Healthcare's 5-year EBITDA Margin high stood at 44.38% for Q4 2023, and its period low was 86.09% during Q1 2023.
  • Over the past 5 years, Sensus Healthcare's median EBITDA Margin value was 13.21% (recorded in 2024), while the average stood at 0.13%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first surged by 2124400bps in 2021, then tumbled by -1241000bps in 2023.
  • Sensus Healthcare's EBITDA Margin (Quarter) stood at 40.84% in 2021, then decreased by -22bps to 31.84% in 2022, then skyrocketed by 39bps to 44.38% in 2023, then tumbled by -70bps to 13.21% in 2024, then crashed by -383bps to 37.32% in 2025.
  • Its last three reported values are 37.32% in Q3 2025, 26.56% for Q2 2025, and 31.71% during Q1 2025.